SERMORELIN ACETATE 10mg
$ 75.00
Sermorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) that has been widely researched for its role in stimulating endogenous growth hormone production. It functions by activating the pituitary gland to naturally secrete growth hormone, rather than replacing it exogenously. Scientific investigations highlight Sermorelin’s potential to enhance bone mineral density, support tissue regeneration, minimize fibrotic scarring, mitigate neurodegenerative decline such as dementia, and exhibit neuroprotective effects that may help reduce seizure frequency and severity.
Buy More, Save More
| from 5 pcs. | from 10 pcs. | from 20 pcs. |
|---|---|---|
Storage Instructions:| All of our products are manufactured using the Lyophilization (Freeze Drying) process, which ensures that our products remain 100% stable for shipping for up to 3-4 months. Once the peptides are reconstituted (mixed with bacteriostatic water), they must be stored in the fridge to maintain stability. After reconstitution, the peptides will remain stable for up to 30 days. Lyophilization is a unique dehydration process, also known as cryodesiccation, where the peptides are frozen and then subjected to low pressure. This causes the water in the peptide vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure known as lyophilized peptide. The puffy white powder can be stored at room temperature until you're ready to reconstitute it with bacteriostatic water. Once peptides have been received, it is imperative that they are kept cold and away from light. If the peptides will be used immediately, or in the next several days, weeks or months, short-term refrigeration under 4C (39F) is generally acceptable. Lyophilized peptides are usually stable at room temperatures for several weeks or more, so if they will be utilized within weeks or months such storage is typically adequate. However, for longer term storage (several months to years) it is more preferable to store peptides in a freezer at -80C (-112F). When storing peptides for months or even years, freezing is optimal in order to preserve the peptide’s stability. For further information on proper storage techniques, click the link below: Peptide Storage Information
GLP1-S Molecular Structure
Source: PubChem
Amino Acid Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4113.58 g/mol
PubChem CID: 56843331
CAS Number: 910463-68-2
Common Synonyms: Semaglutide, NN9535, OG217SC, NNC 0113-0217, GLP-1 Receptor Agonist (GLP-1RA), Long-Acting GLP-1 Analog
Sermorelin Peptide Research
1. Cardiovascular Health and Tissue Remodeling
Cardiac injury, such as myocardial infarction (heart attack), can lead to long-term complications including heart failure, arrhythmias, reduced stamina, and chronic cardiac pain. Much of this decline results from cardiac remodeling—a process where scar tissue forms not only at the site of injury but also spreads to surrounding healthy tissue. This structural remodeling contributes to functional decline and increased mortality risk over time.
Recent animal studies have demonstrated that Sermorelin, a growth-hormone-releasing hormone (GHRH) analogue, may counteract these effects. In controlled trials involving porcine models, Sermorelin administration was shown to:
Decrease cardiomyocyte (heart cell) death
Stimulate extracellular matrix synthesis to promote optimal tissue repair
Encourage neovascularization (formation of new blood vessels)
Downregulate inflammatory markers that drive fibrosis
Collectively, these outcomes resulted in smaller scar formation, enhanced diastolic performance, and improved vascularization. Current research continues to evaluate Sermorelin’s potential role in treating chronic heart failure and valvular disease, indicating its promise beyond acute cardiac injury models.
2. Neurological Research: Epilepsy and GABA Regulation
Gamma-aminobutyric acid (GABA) is the brain’s principal inhibitory neurotransmitter, essential for maintaining balanced electrical activity in the nervous system. Abnormalities in GABA signaling are implicated in seizure disorders and other neurological dysfunctions.
Preclinical studies show that Sermorelin and other GHRH analogues may modulate neuronal excitability by interacting with GABA receptors. This GABAergic activity has been associated with decreased seizure frequency and intensity in experimental models. While further studies are underway, these findings position Sermorelin as a potential research candidate in neuroprotective and anticonvulsant applications, particularly for treatment-resistant epilepsy.
3. Sermorelin and Sleep Regulation
Sleep quality and restorative biological processes are closely tied to hormonal balance—specifically, growth hormone secretion regulated by the GHRH axis. Research involving animal models, including rainbow trout, suggests that Sermorelin may stimulate orexin—a neuropeptide responsible for maintaining sleep-wake cycles and promoting deep, regenerative rest.
These findings support the hypothesis that Sermorelin could enhance sleep quality and aid recovery in individuals with circadian rhythm disturbances or metabolic imbalances linked to inadequate GH release. Ongoing investigations aim to clarify Sermorelin’s effect on orexin pathways and its broader role in sleep physiology.
4. Advantages of Sermorelin Over Exogenous Growth Hormone
Sermorelin functions as a natural secretagogue, stimulating the pituitary gland to release endogenous growth hormone rather than introducing synthetic GH into circulation. This key distinction allows the body to regulate hormone levels through natural feedback mechanisms—greatly reducing risks of overdose, edema, joint discomfort, or metabolic dysregulation commonly associated with direct GH therapy.
Furthermore, studies indicate that Sermorelin does not induce tachyphylaxis—a tolerance effect that requires escalating doses for continued efficacy. Instead, it appears to upregulate GHRH receptor expression, maintaining its effectiveness during prolonged administration. This stability makes Sermorelin a preferred research model for exploring long-term GH regulation without receptor desensitization.
Summary
Laboratory studies indicate that Sermorelin may hold potential in diverse fields of research including cardiovascular regeneration, neuroprotection, and metabolic restoration. Early data supports its ability to enhance tissue repair, improve sleep regulation, and safely promote natural GH release mechanisms.
Note: Sermorelin exhibits moderate side effects, low oral bioavailability, and excellent subcutaneous absorption in animal studies. Per-kilogram dosages in animals do not directly translate to human use.
All Sermorelin Peptide products available through 1stPharma.com are supplied strictly for in vitro scientific research and educational purposes. These compounds are not approved by the FDA for human or veterinary use, diagnosis, or treatment of any medical condition.
| Packing | 10mg |
|---|
Reviews
There are no reviews yet.